Laurie J Rich1, Mukund Seshadri. 1. From the Departments of Molecular and Cellular Biophysics (L.J.R., M.S.), Pharmacology and Therapeutics (M.S.) and Head and Neck Surgery (M.S.), Roswell Park Cancer Institute, CGP L4-314, Elm and Carlton Streets, Buffalo, NY 14263.
Abstract
PURPOSE: To noninvasively assess vascular hemodynamics with photoacoustic imaging (PAI) and blood oxygenation level-dependent (BOLD) magnetic resonance (MR) imaging in phantoms and in an animal model. MATERIALS AND METHODS: In vivo studies were performed with institutional animal care and use committee approval. In vitro experiments were performed by using a tissue-mimicking phantom in multiple oxygenation conditions (n = 6) to compare PAI measurements and BOLD MR imaging measurements. PAI and T2-weighted spin-echo-based BOLD MR imaging were performed to assess tumor response to carbogen (95% O2, 5% CO2) in mice with head and neck tumors before (n = 11) and after (n = 9) treatment with a vascular disrupting agent (VDA). Two-tailed Pearson correlation analysis was performed to determine the correlation between the parameters measured with PAI and BOLD MR imaging in vitro. Two-tailed paired t tests were used to compare change in tumor hemoglobin oxygen saturation (sO2) levels and BOLD signal in response to carbogen. Changes in PAI and BOLD signal intensity before and after VDA treatment were analyzed for significance by using analysis of variance with repeated measures. RESULTS: Phantom measurements yielded good correlation between photoacoustically derived sO2 levels and BOLD signal intensity (r = 0.937, P = .005) and partial pressure of oxygen (r = 0.981, P = .005). In vivo hemodynamic response to carbogen was characterized by a significant increase in tumor sO2 levels (P = .003) and BOLD signal (P = .001). When compared with pretreatment estimates, treatment with VDA resulted in a significant reduction in the tumor hemodynamic response to carbogen at PAI (P = .030). CONCLUSION: Carbogen-based functional imaging with PAI and BOLD MR imaging enables monitoring of early changes in tumor hemodynamics after vascular targeted therapy.
PURPOSE: To noninvasively assess vascular hemodynamics with photoacoustic imaging (PAI) and blood oxygenation level-dependent (BOLD) magnetic resonance (MR) imaging in phantoms and in an animal model. MATERIALS AND METHODS: In vivo studies were performed with institutional animal care and use committee approval. In vitro experiments were performed by using a tissue-mimicking phantom in multiple oxygenation conditions (n = 6) to compare PAI measurements and BOLD MR imaging measurements. PAI and T2-weighted spin-echo-based BOLD MR imaging were performed to assess tumor response to carbogen (95% O2, 5% CO2) in mice with head and neck tumors before (n = 11) and after (n = 9) treatment with a vascular disrupting agent (VDA). Two-tailed Pearson correlation analysis was performed to determine the correlation between the parameters measured with PAI and BOLD MR imaging in vitro. Two-tailed paired t tests were used to compare change in tumor hemoglobin oxygen saturation (sO2) levels and BOLD signal in response to carbogen. Changes in PAI and BOLD signal intensity before and after VDA treatment were analyzed for significance by using analysis of variance with repeated measures. RESULTS: Phantom measurements yielded good correlation between photoacoustically derived sO2 levels and BOLD signal intensity (r = 0.937, P = .005) and partial pressure of oxygen (r = 0.981, P = .005). In vivo hemodynamic response to carbogen was characterized by a significant increase in tumorsO2 levels (P = .003) and BOLD signal (P = .001). When compared with pretreatment estimates, treatment with VDA resulted in a significant reduction in the tumor hemodynamic response to carbogen at PAI (P = .030). CONCLUSION:Carbogen-based functional imaging with PAI and BOLD MR imaging enables monitoring of early changes in tumor hemodynamics after vascular targeted therapy.
Authors: Laura M Parkes; Jens V Schwarzbach; Annemieke A Bouts; Roel H R Deckers; Pim Pullens; Christian M Kerskens; David G Norris Journal: Magn Reson Med Date: 2005-12 Impact factor: 4.668
Authors: Vikram S Dogra; Bhargava K Chinni; Keerthi S Valluru; Jacob Moalem; Ellen J Giampoli; Katie Evans; Navalgund A Rao Journal: AJR Am J Roentgenol Date: 2014-06 Impact factor: 3.959
Authors: Andrew Needles; Andrew Heinmiller; John Sun; Catherine Theodoropoulos; David Bates; Desmond Hirson; Melissa Yin; F Stuart Foster Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2013-05 Impact factor: 2.725
Authors: Sarah E Bohndiek; Laura S Sasportas; Steven Machtaler; Jesse V Jokerst; Sharon Hori; Sanjiv S Gambhir Journal: J Nucl Med Date: 2015-08-27 Impact factor: 10.057
Authors: Liliya M Yamaleyeva; Yao Sun; Tiffaney Bledsoe; Asia Hoke; Susan B Gurley; K Bridget Brosnihan Journal: FASEB J Date: 2017-08-21 Impact factor: 5.191
Authors: Binita Shrestha; Frank DeLuna; Mark A Anastasio; Jing Yong Ye; Eric M Brey Journal: Tissue Eng Part B Rev Date: 2020-01-14 Impact factor: 6.389
Authors: Andres M Arias Lorza; Harshan Ravi; Rohit C Philip; Jean-Philippe Galons; Theodore P Trouard; Nestor A Parra; Daniel D Von Hoff; William L Read; Raoul Tibes; Ronald L Korn; Natarajan Raghunand Journal: Sci Rep Date: 2020-09-02 Impact factor: 4.379